Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a Day
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 219 participants.
Also called NCT01234597
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 219 participants
- Sponsor
- Registry
-
NCT01234597
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Israel
- Registry status
- Completed
Technical summary
Registry record NCT01234597. Randomized; no masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2015-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a Day
- Acronym
- SeLan
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- INSULIN GLARGINE (HOE901)
- Intervention (Drug)
- INSULIN GLULISINE (HMR1964)
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct01234597- Content hash
523c804cf071fe96d88f50aee04330c50ec2d65b9d34f483858c5c9686d6ae64